CD274 and gastric cancer: Research on GC immunotherapy by Kohei Shitara et al. can show that PD-L1 expression alone is not sufficient to screen people who can benefit fully from immunotherapy, and new efficacy-related markers must be sought to help further optimize patient selection for GC patients.